A group of U.S. senators sent a letter to HHS urging it to drop its appeal of a federal court decision that limits the use of copay accumulators. Copay accumulators prevent copay assistance from counting towards patients’ deductibles and out-of-pocket maximums. The court decision allows the use of these programs only for brand-name medications with generic equivalents. The senators argued that dropping the appeal would ensure Americans receive cost-sharing protections for their expensive medications, leading to improved adherence and decreased medical costs. They also criticized health plans for using copay accumulators as a profit-seeking tactic, resulting in financial hardship and barriers to accessing life-saving medicines for patients.
Source link
19 Senators Urge HHS to Drop Appeal That Would Jeopardize Americans’ Access to Life-Saving Drugs
